|Articles|August 9, 2021

The Importance of Pharmacists in Antimicrobial Stewardship Programs

Author(s)Killian Meara

A conversation with Anna Legreid Dopp, Pharm. D.

Antimicrobial stewardship, the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients, is one of the most important issues today when it comes to antimicrobial resistance.

Optimizing the use of antibiotics is critical to effectively treat infections, protect patients from harms caused by unnecessary antibiotic use, and combat antibiotic resistance.

Previous studies have demonstrated that when institutions utilize antibiotic stewardship programs, they see a decrease in not only antibiotic use, but cost and associated infections as well.

When it comes to implementing these programs, pharmacists are of critical importance, as they are core members of the team and have an abundance of knowledge.

Contagion recently sat down with Anna Legreid Dopp, Pharm. D, senior director of clinical guidelines and quality improvement at the American Society of Health-System Pharmacists, to discuss the importance of pharmacists in antimicrobial resistance.

“Pharmacists are medication experts,” Dopp said. “They understand everything there is to know about the medication use cycle, from procuring the medication, to having it prescribed, to its being administered, to monitoring the patient and then evaluating how their program is working.”

“Pharmacists bring knowledge that’s unique and adds a lot of value to antimicrobial stewardship programs.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.